Deductions made after May 17, 2018 are tax deductible. It is retroactive to when the application was made. (Prior to May 2018, all donations went to M...
Hello Sandra, Thanks again for posting on the forum and sharing your story. I hope your scan on Feb 13th is a good one. We would like to hear the resu...
Thank you for sharing your story Hope. Coincidentally, I was treated by Dr. Nick when she was at MD Anderson and I was a patient there. I think she is...
Hello Darryl, I spoke with Dr. Birrer yesterday about this trial. Dr. Birrer believes that it is a good trial if they accept GCS patients. Further he...
Hello Debbie, I am eager to hear about your experience with Opdivo and Avastin. My treatment team is talking about off label opdivo as a next step. ...
Thanks Jen for sharing the information about your mother. I am so happy she found a good treatment team. I was also diagnosed at Stage 4b and I contin...
Andrea, Thank you so much for sharing your incredible story. 17 hours of surgery followed by 12 hours of surgery! And the brutal chemo regimen. You ...
Debbie, I was so happy to read about your treatment with Opdivo. The GCS Project is supporting the launch of a clinical trial with Opdivo and another ...
Reminder: This is most likely your insurance carriers enrollment period. Being diagnosed with a rare disease can be very expensive. You may have to ...
The first dedicated Gynecological Carcinosarcoma Clinic in the country (maybe the world) is now seeing GCS patients. The clinic is staffed by Dr. Mich...
This is so interesting. I am going to follow up and learn more. Sounds groundbreaking! Thank you for sharing. Diane
Hello Allie, Thanks for sharing your story. I think your treatment speaks to the variation of treatment for this cancer. I was also diagnosed at Sta...
Was your cancer uterine? Congratulations on the clean scan. Where were you treated? Thanks for posting
Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »
Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »
Clinical trials are currently being offered at Medical University of South Carolina (MUSC) Health Care in Charleston SC. A Phase II/III Study of Paciltaxel/Carboplatin alone, or combined with either Trastuzumab… Read More »